Evofosfamide Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
RNXT | F | RenovoRx, Inc. | -3.94 | |
CNSP | F | CNS Pharmaceuticals, Inc. | 2.60 | |
MTEM | F | Molecular Templates, Inc. | -3.19 |
Related Industries: Biotechnology
Related Stock Lists:
Cancer
Cancer Treatment
Oncology
Solid Tumors
Biopharmaceutical
Blastoma
Brain Tumor
Central Nervous System Tumors
Chemical Elements
Clinical Medicine
Drugs
Gastrointestinal Cancer
Gemcitabine
Glioblastoma
Lymphoma
Medicine
Nitrogen Mustards
Oncolytics Biotech
Oxygen
Pancreatic Cancer
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IWC | B | iShares Microcap ETF | 0.0 | |
VXF | C | Vanguard Extended Market ETF | 0.0 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Cancer
Cancer Treatment
Oncology
Solid Tumors
Biopharmaceutical
Blastoma
Brain Tumor
Central Nervous System Tumors
Chemical Elements
Clinical Medicine
Drugs
Gastrointestinal Cancer
Gemcitabine
Glioblastoma
Lymphoma
Medicine
Nitrogen Mustards
Oncolytics Biotech
Oxygen
Pancreatic Cancer
- Evofosfamide
Evofosfamide (INN, USAN; formerly known as TH-302) is an investigational hypoxia-activated prodrug that is in clinical development for cancer treatment. The prodrug is activated only at very low levels of oxygen (hypoxia). Such levels are common in human solid tumors, a phenomenon known as tumor hypoxia.Evofosfamide is being evaluated in clinical trials for the treatment of multiple tumor types as a monotherapy and in combination with chemotherapeutic agents and other targeted cancer drugs.
Dec 2015 : two Phase 3 trials fail, Merck will not apply for a license
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles